Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR)


$8.2900
-0.0099 ( +3.63% ) 2.9K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$8.2900

Previous close


$8.2999

Volume


2.9K

Market cap


$38.72M

Day range


$8.0650 - $8.1850

52 week range


$7.1900 - $10.0400

SEC Filings


Form Type Description Pages Date
nt-ncsr/a Quarterly Reports 1 Mar 08, 2024
4 Insider transactions 1 Mar 06, 2024
nt-ncsr/a Quarterly Reports 1 Feb 29, 2024
nt-ncsr Quarterly Reports 1 Feb 29, 2024
8-k 8K-related 14 Jan 02, 2024
4 Insider transactions 1 Dec 06, 2023

Latest News